- Home
- J vs NBIX Comparison
J vs NBIX Comparison
Compare J & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- J
- NBIX
- Stock Information
- Founded
- J 1947
- NBIX 1992
- Country
- J United States
- NBIX United States
- Employees
- J 45000
- NBIX N/A
- Industry
- J Military/Government/Technical
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- J Industrials
- NBIX Health Care
- Exchange
- J Nasdaq
- NBIX Nasdaq
- Market Cap
- J 15.1B
- NBIX 12.2B
- IPO Year
- J N/A
- NBIX 1996
- Fundamental
- Price
- J $127.34
- NBIX $126.55
- Analyst Decision
- J Buy
- NBIX Strong Buy
- Analyst Count
- J 8
- NBIX 20
- Target Price
- J $150.86
- NBIX $163.20
- AVG Volume (30 Days)
- J 668.9K
- NBIX 915.2K
- Earning Date
- J 08-05-2025
- NBIX 07-31-2025
- Dividend Yield
- J 0.93%
- NBIX N/A
- EPS Growth
- J N/A
- NBIX N/A
- EPS
- J 3.66
- NBIX 2.96
- Revenue
- J $11,686,906,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- J N/A
- NBIX $16.29
- Revenue Next Year
- J $6.06
- NBIX $15.08
- P/E Ratio
- J $34.64
- NBIX $42.49
- Revenue Growth
- J 35.39
- NBIX 21.73
- 52 Week Low
- J $105.18
- NBIX $84.23
- 52 Week High
- J $149.05
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- J 53.26
- NBIX 64.01
- Support Level
- J $125.56
- NBIX $122.66
- Resistance Level
- J $130.38
- NBIX $126.00
- Average True Range (ATR)
- J 1.96
- NBIX 2.55
- MACD
- J -0.11
- NBIX -0.33
- Stochastic Oscillator
- J 55.49
- NBIX 72.06
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.